EP 107
Pill imprint EP 107 has been identified as Acetazolamide extended release 500 mg.
Acetazolamide is used in the treatment of mountain sickness / altitude sickness; hydrocephalus; glaucoma; epilepsy; edema (and more), and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy.
Acetazolamide 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Acetazolamide extended release Images
- Imprint:
-
EP
107 - Strength:
- 500 mg
- Color:
- Orange & White
- Size:
- 25.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- FD&C Yellow No. 6
gelatin
microcrystalline cellulose
sodium lauryl sulfate
magnesium silicate
titanium dioxide
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
Carbonic anhydrase inhibitors - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Zydus Pharmaceuticals
- National Drug Code (NDC):
- 68382-0261
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0401 | Amerisource Health Services |
Note: Inactive ingredients may vary.
Advertisement
More Acetazolamide Extended Release resources
- Acetazolamide (Wolters Kluwer)
- Acetazolamide Solution (Wolters Kluwer)
- Acetazolamide Sustained-Release Capsules (Wolters Kluwer)
- acetazolamide (Cerner Multum)
- Acetazolamide (AHFS DI)
- Acetazolamide Sodium (AHFS DI)
- Acetazolamide (FDA)
- Acetazolamide Capsules (FDA)
- Acetazolamide Tablets (FDA)
- Acetazolamide (Wolters Kluwer)
Search Again
